Christopher Mason
Director/Board Member at KRYSTAL BIOTECH, INC.
Net worth: - $ as of 2024-02-28
Profile
Christopher Mason is an entrepreneur who founded 5 companies, among them: Avrobio, Inc., Oribiotech Ltd.
and London Regenerative Medicine Network Ltd.
Currently, he is Chief Executive Officer & Director at Sun Vectors, Inc. (which he founded in 2022).
He is also on the board of Alliance for Regenerative Medicine, Krystal Biotech, Inc., Oribiotech Ltd.
and London Regenerative Medicine Network Ltd.
and Professor at University College London.
In his past career Dr. Mason held the position of Chief Scientific Officer for Avrobio, Inc. (he founded the company in 2015) and Director at Stem Cell Translation Ltd.
Dr. Mason received a doctorate from King's College London, an undergraduate degree from Imperial College London and a doctorate from University College London.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
KRYSTAL BIOTECH, INC.
-.--% | 2023-06-29 | 0 ( -.--% ) | - $ | 2024-02-28 |
Christopher Mason active positions
Companies | Position | Start |
---|---|---|
KRYSTAL BIOTECH, INC. | Director/Board Member | 2021-01-03 |
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Founder | 2015-08-31 |
London Regenerative Medicine Network Ltd. | Founder | 2008-01-31 |
University College London | Corporate Officer/Principal | - |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | 2021-09-30 |
Former positions of Christopher Mason
Companies | Position | End |
---|---|---|
AVROBIO, INC. | Founder | 2022-06-29 |
Stem Cell Translation Ltd. | Founder | 2018-02-28 |
The British Neurological Research Trust | Director/Board Member | 2016-04-30 |
UK Stem Cell Foundation | Director/Board Member | 2016-04-30 |
Training of Christopher Mason
Imperial College London | Undergraduate Degree |
University College London | Doctorate Degree |
King's College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
AVROBIO, INC. | Health Technology |
KRYSTAL BIOTECH, INC. | Health Technology |
Private companies | 6 |
---|---|
UK Stem Cell Foundation | Miscellaneous |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
The British Neurological Research Trust | |
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
London Regenerative Medicine Network Ltd. | |
Stem Cell Translation Ltd. |